Thermo Fisher set to benefit from demand for testing kits, vaccines
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Thermo Fisher Scientific (TMO) PT Raised to $715 at Cowen
October 28, 2021 8:07 AM EDTCowen analyst Dan Brennan raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $715.00 (from $696.00) while maintaining an Outperform rating.
The analyst commented, "TMO reported a good 3Q, with COVID testing a big driver along with healthy organic growth ex-COVID of 10%... More
Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.09
October 27, 2021 6:09 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.76, $1.09 better than the analyst estimate of $4.67. Revenue for the quarter came in at $9.33 billion versus the consensus estimate of $8.39 billion.
GUIDANCE:
Thermo Fisher Scientific sees FY2021 EPS of $23.37, versus the consensus of... More
